Drug Price Trends for FT ALL DAY ALLERGY-D

Average Pharmacy Cost for FT ALL DAY ALLERGY-D

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
FT ALL DAY ALLERGY-D 5-120 MG TB	70677-1020-01	0.55435	EACH	2024-12-18
FT ALL DAY ALLERGY-D 5-120 MG TB	70677-1020-01	0.53133	EACH	2024-11-20
FT ALL DAY ALLERGY-D 5-120 MG TB	70677-1020-01	0.58061	EACH	2024-10-23
FT ALL DAY ALLERGY-D 5-120 MG TB	70677-1020-01	0.57676	EACH	2024-09-18
FT ALL DAY ALLERGY-D 5-120 MG TB	70677-1020-01	0.59151	EACH	2024-08-21

FT ALL DAY ALLERGY-D Market Analysis and Financial Projection

Market Analysis and Price Projections for All Day Allergy-D

Introduction to All Day Allergy-D

All Day Allergy-D, a combination of cetirizine and pseudoephedrine, is a widely used medication for treating allergic rhinitis and other upper respiratory allergies. This drug is part of the larger allergy treatment market, which is experiencing significant growth due to various factors.

Global Allergy Treatment Market Overview

The global allergy diagnostics and therapeutics market was estimated at USD 33.06 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2030. This growth is driven by the rising prevalence of allergy disorders, especially among children and the geriatric population, as well as increasing adoption of in vitro diagnostic (IVD) techniques and improving access to diagnostic tools in developing countries[1].

Market Drivers

Several key factors are driving the growth of the allergy treatment market:

Therapeutics Segment

The therapeutics segment, which includes medications like All Day Allergy-D, held the largest revenue share of over 81.67% in 2023. Therapeutics are focused on treating allergic conditions, and drugs like epinephrine and antihistamines dominate this segment due to their effectiveness in alleviating symptoms and providing relief from allergies[1].

Diagnostics Segment

Although smaller, the diagnostics segment is anticipated to witness the fastest CAGR over the forecast period due to the increasing demand for precise and early identification of allergic conditions. Diagnostic tools, such as allergen microarray kits, are becoming more sensitive and provide individualized patient assessment and monitoring[1].

Lifestyle and Environmental Factors

Changing lifestyles, growing pollution, unhealthy habits like smoking, and urbanization are contributing to the increasing incidence of allergic conditions. These factors are expected to continue driving the demand for allergy treatments[1][3].

Price Analysis of All Day Allergy-D

The cost of All Day Allergy-D can vary based on the form, quantity, and pharmacy.

Oral Tablet, Extended Release

• The cost for All Day Allergy-D (5 mg-120 mg) oral tablet, extended release, is around $14 for a supply of 24 tablets. Prices can range from $0.57 to $0.60 per unit, depending on the pharmacy and any discounts applied[2].
• Here is a breakdown of the prices:
  • 24 tablets: $13.60
  • Generic versions: Starting from $11.55 for 12 tablets[2].

Generic and Discount Options

Generic versions of cetirizine/pseudoephedrine are available, which can significantly reduce the cost. For example, generic cetirizine/pseudoephedrine prices start from $11.55 for 12 tablets. Additionally, discount cards and coupons can further reduce the cost, with some programs offering savings of up to 80%[2][5].

Regional Market Dynamics

The allergy treatment market is geographically diverse, with different regions contributing to its growth.

North America

North America dominated the allergy diagnostics and therapeutics market with a share of 36.44% in 2023. This is attributable to the high incidence of respiratory allergic disorders and rising awareness levels about allergy diagnostics and the adoption of in vitro blood tests in the region[1].

Asia-Pacific

The Asia-Pacific region is also a significant market due to improving access to diagnostic tools and increasing adoption of IVD techniques. The growing incidence of allergic conditions in this region, driven by factors like industrialization and air pollution, presents future growth opportunities[1].

Product Type Analysis

H-1 Blockers

In the context of antihistamines, H-1 Blockers, which include drugs like cetirizine, dominate the market. These drugs are preferred for their efficacy in treating allergies such as hay fever, hives, and other allergic conditions. They are known for their minimal sedative effects compared to first-generation antihistamines, making them suitable for daily use[4].

Prescription-Based vs. OTC

The prescription-based segment holds a dominant position in the antihistamines market, capturing more than 64.6% of the market share. This indicates a strong reliance on professional healthcare advice for managing allergies. However, over-the-counter (OTC) antihistamines also have a steady demand due to their convenience and ease of access[4].

Distribution Channel Analysis

Retail Pharmacies

Retail pharmacies hold a dominant market position in the distribution of antihistamines, capturing more than 41.7% of the market share. This is due to their accessibility and convenience, offering immediate access to medications without the need for a doctor’s visit[4].

Key Takeaways

• Market Growth: The global allergy diagnostics and therapeutics market is projected to grow significantly, driven by increasing prevalence of allergies and advancements in diagnostic and therapeutic techniques.
• Therapeutics Dominance: The therapeutics segment, including medications like All Day Allergy-D, dominates the market due to its effectiveness in treating allergic conditions.
• Generic and Discount Options: Generic versions and discount options can significantly reduce the cost of All Day Allergy-D.
• Regional Dynamics: North America and the Asia-Pacific region play crucial roles in market growth due to high incidence rates and improving healthcare access.

FAQs

1. What is the current market size of the global allergy diagnostics and therapeutics market? The global allergy diagnostics and therapeutics market size was estimated at USD 33.06 billion in 2023[1].

2. What is the projected CAGR for the global allergy diagnostics and therapeutics market from 2024 to 2030? The market is projected to grow at a CAGR of 8.7% from 2024 to 2030[1].

3. Which segment dominates the allergy diagnostics and therapeutics market? The therapeutics segment holds the largest revenue share, with over 81.67% of the market in 2023[1].

4. What are the key factors driving the growth of the allergy treatment market? Key factors include the rising prevalence of allergy disorders, increasing adoption of IVD techniques, improving access to diagnostic tools, and lifestyle and environmental changes[1][3].

5. How much does All Day Allergy-D typically cost? The cost for All Day Allergy-D (5 mg-120 mg) oral tablet, extended release, is around $14 for a supply of 24 tablets, with generic versions starting from $11.55 for 12 tablets[2].

Sources

1. Grand View Research: Allergy Diagnostics And Therapeutics Market Report, 2030.
2. Drugs.com: All Day Allergy-D Prices, Coupons, Copay Cards & Patient Assistance.
3. GlobeNewswire: Allergy Treatment Market Size and Share Projected to Surpass USD 34.9 Billion by 2034 at 5.8% CAGR.
4. Market.us: Antihistamines Market Size, Share | CAGR Of 8.1%.
5. DrugPatentWatch: Market Analysis and Financial Projection for All Day Allergy.